Slashdot Mirror


Are TV Pharmaceutical Ads Damaging?

trivialscene asks: "ABC News is carrying an article about a recently published study in the medical research journal Annals of Family Medicine which examined prime time television ads run by pharmaceutical companies. The researchers concluded that the generally ambiguous ads, which appeal almost entirely to emotion rather than fact, tend to confuse viewers. They also suggest that the ads may be creating problems at the doctor's office, as some people might become convinced they need a particular medication and insist on getting it, rather than leaving the decision to trained medical professionals. What do you think about the presence of drug advertisements on television?"

7 of 383 comments (clear)

  1. not sure by gEvil+(beta) · · Score: 4, Funny

    I dunno. I'm still trying to convince my doctor that Levitra helps you levitate.

    --
    This guy's the limit!
  2. Who cares? by Captain+Splendid · · Score: 4, Funny

    All that matters is that there are pills that give me erections for hours on end. Balanced against that, who cares about the dumb viewing public?

    --
    Linux, you magnificent bastard, I read the fucking manual!
    1. Re:Who cares? by gwayne · · Score: 5, Funny

      All that matters is that there are pills that give me erections for hours on end.

      You need pills for that? Sheesh, what's this country coming to?

  3. Re:Not for me by SuperficialRhyme · · Score: 5, Funny

    Damn, I could have diagnosed you from your slashdot nick.

  4. Re:The way I see it... by gEvil+(beta) · · Score: 5, Funny

    So how's the acting career coming along?

    --
    This guy's the limit!
  5. Re:Ask your doctor about modding parent up. by Citizen+of+Earth · · Score: 5, Funny

    "If you want the professional medical opinion of your television, visit it instead of me. You're not buying dishwashing liquid here."

    You're seeing Dr. House?

  6. Re:marketing vs R&D by slughead · · Score: 3, Funny

    That, of course, means we'd get five times the R&D for the same money we're paying today if we paid for it outright rather than granting monopolies. Or we'd get the same level of R&D at a fifth of the price.

    Oh of COURSE that's what it means.

    Maybe they need that marketing to sell the drugs to pay for the R&D to make the drugs and the best way to do that is to pay for more advertisements.

    You think companies like to advertise? They would rather give the money to R&D if the drugs actually sold themselves. Most drugs, however, do not sell themselves. Most of the medication sold in this country has little effect or could easily be replaced by an older drug which is 1/10 the cost and only 3 to 4% less effective.

    Another problem is that if the patient dies, that '3 to 4%' figure is brought up in COURT in the form of a malpractice suit against the doctor that prescribed the alternative!

    The niche medications which treat ailments that effect 1% of the population have a high price and the research in finding them is often NEVER PAID OFF. It's a tightly held secret that drug companies often pursue avenues that yield JACK SQUAT.

    The worthless 'celebrex' and 'nexium' medications pay for those dead ends and niche drugs. And their marketing allows them to do that.

    Drugs like Celebrex which show barely any improvement over placebo, and medications that take care of problems related to obesity (a relatively easily-cured disease) wouldn't be flying off the counters if it weren't for those commercials.

    If the drug companies cut their marketing in half, freeing up 20% of their revenue according to your figures (which, btw, are wrong), they may end up having half the revenue to work with. So they'd have -50% less money and +20% more, for a net of -30%. Those are obviously arbitrary figures, but you can see the point: less marketing does not mean more money for R&D.

    So, to sum up, the pharmaceutical system in the US is the best money could buy. If central planning were the answer, the US wouldn't be lapping the socialized world in pharmacological research. When government starts telling doctors what to prescribe and price fixing on drugs in America, we'll see a quick restructuring inside these companies in which R&D will fall through the floor.